US Cancer Biomarker Market Size, Share, Analysis, Industry Report and Forecast 2019-2025
US cancer biomarker market is anticipated to grow at a CAGR of 11.8% during the forecast period. The US cancer biomarker market in the North American region is dominating due to various factors such as investments in research and development, high healthcare expenditure, presence of key players and rising prevalence of cancer patients.
The proactiveness of prostate cancer research organizations in the US are contributing to the market growth. Many organizations fund researchers for supporting their study for cancer research and bringing innovative treatments to the market. There are many organizations working in the US that are creating awareness regarding prostate cancer in men. US Too-International, Prostate Cancer Education and Support network and the Prostate cancer research organization are some of the organizations in the category. There are special organizations as well in the US, for instance, Malecare is a cancer support organization offering help and assistance to gay people with prostate cancer and other cancers. These organizations are increasing public knowledge for prostate cancer and educating them regarding the treatments available in the country. Hence, contributing to the US cancer biomarker market.
To Request a Sample of our Report on US Cancer Biomarker Market: https://www.omrglobal.com/request-sample/us-cancer-biomarker-market
According to the American Cancer
Society in 2017, it was estimated that out of total 600,920 cancer deaths in
the US, around 190,500 would be caused by cigarette smoking. In addition, it
was estimated by the World Cancer Research Fund that 20% of cancers are caused
by f factors such as physical inactivity, excess body weight, excess alcohol
consumption and poor nutrition. Cancer is usually developed among older people.
According to the American Cancer Society in 2017, 87% of all the cancers in the
US were diagnosed in people with age 50 years and above. These cancers are
preventable. Moreover, colorectal and cervical cancers can be prevented by
screening and by removal of precancerous lesions. Screening also have reduced
the mortality rate significantly for the cancers of colon, breast, and lung.
(Get 15% Discount on Buying this Report)
A full
Report of US Cancer Biomarker Market is Available at: https://www.omrglobal.com/industry-reports/us-cancer-biomarker-market
US Cancer Biomarker Market Segmentation
By Biomarker Type
·
Genetic Biomarker
·
Protein Biomarker
By Cancer Type
·
Lung Cancer
·
Prostate Cancer
·
Breast Cancer
·
Colorectal Cancer
·
Cervical Cancer
·
Other
US Cancer Biomarkers Market by Applications
·
Drug Discovery and Development
·
Diagnosis
·
Risk Assessment
·
Prognostics
By Profiling Technology
·
Omics Technology
·
Immunoassays
·
Cytogenetics
·
Bioinformatics
Company Profiles
·
Abbott laboratories Inc.
·
Astellas Pharma Inc.
·
Becton, Dickson and Co.
·
Bio-Rad Laboratories, Inc.
·
Danaher Corp.
·
F. Hoffmann-La Roche Ltd.
·
Merck and Co., Inc.
·
Novartis AG
·
Pfizer Inc.
·
QIAGEN GmbH
·
Thermo Fisher Scientific Inc.
Reasons to Buying From us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for
Report Customization @ https://www.omrglobal.com/report-customization/us-cancer-biomarker-market
About Orion
Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an experienced
team of analysts and consultants. OMR offers quality syndicated research
reports, customized research reports, consulting and other research-based
services.
For
More Information, Visit Orion Market Research
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment